Sabal Trust’s Cardinal Health CAH Stock Holding History

Sabal Trust’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,074	Closed	-$255K	–	137
2018 Q1	$255K	Buy	+4,074	New	+$279K	0.02%	142
2014 Q2	–	Sell	-2,986	Closed	-$209K	–	106
2014 Q1	$209K	Buy	+2,986	New	+$208K	0.03%	104

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIG

American International Group New York $2.93M AUM 12.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sabal Trust's CAH Position: Q2 2018 in Review

Sabal Trust sold out of Cardinal Health (CAH) in Q2 2018, closing a stake of 4,074 shares — an estimated $255K sold.

Sabal Trust first reported a position in CAH in Q1 2014 and held it in 2 quarters. The position peaked at $255K in Q1 2018. 710 funds tracked by Wall St. Rank hold CAH as of Q2 2018.

Sabal Trust reported no remaining Cardinal Health position as of Q2 2018 after selling out during the quarter.
Sabal Trust sold 4,074 Cardinal Health shares in Q2 2018, an estimated $255K.
Sabal Trust first reported a position in Cardinal Health in Q1 2014 and held it in 2 quarters.
Sabal Trust's Cardinal Health position peaked at $255K in Q1 2018.
710 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2018.

Based on Sabal Trust's 13F filing for Q2 2018, filed 16 Jul 2018.